Loading clinical trials...
Loading clinical trials...
This is a 4-visit, multi-center, randomized, double-masked, vehicle-controlled study evaluating the safety and efficacy of CSF-1 in the temporary correction of presbyopia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Orasis Pharmaceuticals Ltd.
NCT07444658 · Presbyopia
NCT07218731 · Presbyopia Correction, Presbyopia
NCT06060041 · Cataract, Presbyopia, and more
NCT07232615 · Presbyopia Correction, Astigmatism, and more
NCT03135327 · Multiple Sclerosis, Dry Eye Syndromes, and more
Orasis Investigative Site
Chandler, Arizona
Orasis Investigative Site
Mesa, Arizona
Orasis Investigative Site
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions